Model 1 was a univariate analytic model including higher FGF21 (defined according to the cutoff mentioned above), higher NT-pro-BNP (defined according to the cutoff mentioned above), and gender, age, smoker, family history of CVD, diabetes, hypertension and dyslipidemia evaluated separately. This evidence concerns the gene NPPB and metabolic syndrome.